Table 1.
Patients and tumor characteristics.
| Characteristic | TF (n = 8) | T (n = 14) | P-value | ||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Age, years | |||||
| Median | 46 | 55 | |||
| Range | 37–68 | 35–73 | |||
| Hormone receptor and Her2 status | |||||
| ER positive | 8 | 100 | 14 | 100 | |
| PR positive | 6 | 75 | 14 | 100 | |
| HER-2 negative | 8 | 100 | 14 | 100 | |
| Menopausal status | |||||
| Postmenopausal | 5 | 62.5 | 12 | 85.7 | 0.31 |
| Premenopausal | 3 | 37.5 | 2 | 14.3 | |
| LHRHa | 1 | 12.5 | 0 | 0 | |
| Oothecectomy | 2 | 25.0 | 1 | 7.1 | |
| Radical Surgery | |||||
| Yes | 7 | 87.5 | 11 | 78.6 | 1.00 |
| No | 1 | 12.5 | 3 | 21.4 | |
| Disease-free interval | |||||
| <24 m | 2 | 25.0 | 3 | 21.4 | 1.00 |
| >24 m | 5 | 62.5 | 8 | 57.1 | |
| No. of metastatic sites | |||||
| 1 | 1 | 12.5 | 1 | 7.1 | 0.91 |
| 2 | 2 | 25.0 | 4 | 28.6 | |
| ≥3 | 5 | 62.5 | 9 | 64.3 | |
| Metastatic sites | |||||
| Lung | 3 | 37.5 | 9 | 64.3 | 0.38 |
| Liver | 2 | 25.0 | 4 | 28.6 | 1.00 |
| Bone | 5 | 62.5 | 7 | 50 | 0.68 |
| Visceral disease | 5 | 62.5 | 12 | 85.7 | 0.31 |